Logo image of SES

SES AI CORP (SES) Stock Fundamental Analysis

NYSE:SES - New York Stock Exchange, Inc. - US78397Q1094 - Common Stock - Currency: USD

1.01  +0.02 (+2.36%)

After market: 1.01 0 (0%)

Fundamental Rating

3

SES gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 94 industry peers in the Electrical Equipment industry. SES has a great financial health rating, but its profitability evaluates not so good. SES does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SES had negative earnings in the past year.
SES had a negative operating cash flow in the past year.
In the past 5 years SES always reported negative net income.
SES had a negative operating cash flow in each of the past 5 years.
SES Yearly Net Income VS EBIT VS OCF VS FCFSES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of SES (-31.72%) is worse than 60.64% of its industry peers.
Looking at the Return On Equity, with a value of -35.97%, SES is in line with its industry, outperforming 54.26% of the companies in the same industry.
Industry RankSector Rank
ROA -31.72%
ROE -35.97%
ROIC N/A
ROA(3y)-18.36%
ROA(5y)-12.85%
ROE(3y)-21.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SES Yearly ROA, ROE, ROICSES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

Looking at the Gross Margin, with a value of 16.44%, SES is in line with its industry, outperforming 40.43% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for SES so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SES Yearly Profit, Operating, Gross MarginsSES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

8

2. Health

2.1 Basic Checks

SES does not have a ROIC to compare to the WACC, probably because it is not profitable.
SES has more shares outstanding than it did 1 year ago.
SES has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SES. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SES Yearly Shares OutstandingSES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SES Yearly Total Debt VS Total AssetsSES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SES has an Altman-Z score of 4.35. This indicates that SES is financially healthy and has little risk of bankruptcy at the moment.
SES's Altman-Z score of 4.35 is fine compared to the rest of the industry. SES outperforms 78.72% of its industry peers.
There is no outstanding debt for SES. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.35
ROIC/WACCN/A
WACC9.11%
SES Yearly LT Debt VS Equity VS FCFSES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 15.61 indicates that SES has no problem at all paying its short term obligations.
SES's Current ratio of 15.61 is amongst the best of the industry. SES outperforms 96.81% of its industry peers.
SES has a Quick Ratio of 15.60. This indicates that SES is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 15.60, SES belongs to the best of the industry, outperforming 96.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.61
Quick Ratio 15.6
SES Yearly Current Assets VS Current LiabilitesSES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SES have decreased strongly by -87.50% in the last year.
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SES will show a very strong growth in Earnings Per Share. The EPS will grow by 26.23% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y18.55%
EPS Next 2Y20.26%
EPS Next 3Y28.67%
EPS Next 5Y26.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SES Yearly Revenue VS EstimatesSES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
SES Yearly EPS VS EstimatesSES Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SES is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SES Price Earnings VS Forward Price EarningsSES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SES Per share dataSES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

SES's earnings are expected to grow with 28.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.26%
EPS Next 3Y28.67%

More info and screens

0

5. Dividend

5.1 Amount

SES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SES AI CORP

NYSE:SES (6/11/2025, 8:18:18 PM)

After market: 1.01 0 (0%)

1.01

+0.02 (+2.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)N/A N/A
Inst Owners32.69%
Inst Owner Change-12.71%
Ins Owners0.93%
Ins Owner Change1.25%
Market Cap370.52M
Analysts46.67
Price Target1.53 (51.49%)
Short Float %7.7%
Short Ratio1.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.89%
Min EPS beat(2)0.99%
Max EPS beat(2)20.79%
EPS beat(4)4
Avg EPS beat(4)17.51%
Min EPS beat(4)0.99%
Max EPS beat(4)25.74%
EPS beat(8)8
Avg EPS beat(8)30.4%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)50%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)3.85%
EPS NY rev (3m)13.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 47.3
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.38
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.02
BVpS0.74
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.72%
ROE -35.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.44%
FCFM N/A
ROA(3y)-18.36%
ROA(5y)-12.85%
ROE(3y)-21.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.91%
Cap/Sales 81.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.61
Quick Ratio 15.6
Altman-Z 4.35
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)331.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y18.55%
EPS Next 2Y20.26%
EPS Next 3Y28.67%
EPS Next 5Y26.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.41%
EBIT Next 3Y25.18%
EBIT Next 5Y26.42%
FCF growth 1Y-32.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.83%
OCF growth 3YN/A
OCF growth 5YN/A